谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

350MO Omission of Chemotherapy and Addition of the CDK4/6 Inhibitor Ribociclib in HER2-positive and Hormone-Receptor Positive Metastatic Breast Cancer – Second Interim Efficacy Analysis of the Randomized Phase III DETECT V Trial

W. Janni,T.N. Fehm,V. Mueller, A.M.B. de Gregorio, T. Decker,A.D. Hartkopf, M. Just,J. Sagasser, M. Schmidt,P. Wimberger,T. Engler, M. Banys- Paluchowski,P.A. Fasching,B. Rack,A. Schneeweiss, J-U. Blohmer,J. Huober,K. Pantel,T.W.P. Friedl,F. Schochter

Annals of Oncology（2024）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要